The total number of records retrieved from this search are 2. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_4378	Virus nameNewcastle disease virus	Virus strainMTH-68/H	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineHuman malignant melanoma cell line	Cell lineUCSD-24L	Concentration of cell line500 cells per well	In-vitro toxicityNA	AssayLuciferase based ATP assay	In-vitro virus concentration0.798 MOI	In-vitro result50% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedER stress and apoptotic pathway	Immunogenic effectIFN production increased	Clinical trialNA	PMID26408702
IDOV_4391	Virus nameNewcastle disease virus	Virus strainMTH-68/H	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineHuman malignant melanoma cell line	Cell lineUCSD-24L	Concentration of cell line500 cells per well	In-vitro toxicityNA	AssayLuciferase based ATP assay	In-vitro virus concentration2.25 MOI	In-vitro result80% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedER stress and apoptotic pathway	Immunogenic effectIFN production increased	Clinical trialNA	PMID26408702